Related Experiment Video
Updated: Dec 6, 2025

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
Published on: December 10, 2012
The current state of Bayesian methods in nonclinical pharmaceutical statistics: Survey results and recommendations
Paul Faya1, Perceval Sondag2, Steven Novick3
1Statistics-Discovery/Development, Eli Lilly and Company, Indianapolis, Indiana, USA.
Abstract:
The use of Bayesian methods to support pharmaceutical product development has grown in recent years. In clinical statistics, the drive to provide faster access for patients to medical treatments has led to a heightened focus by industry and regulatory authorities on innovative clinical trial designs, including those that apply Bayesian methods. In nonclinical statistics, Bayesian applications have also made advances. However, they have been embraced far more slowly in the nonclinical area than in the clinical counterpart. In this article, we explore some of the reasons for this slower rate of adoption. We also present the results of a survey conducted for the purpose of understanding the current state of Bayesian application in nonclinical areas and for identifying areas of priority for the DIA/ASA-BIOP Nonclinical Bayesian Working Group. The survey explored current usage, hurdles, perceptions, and training needs for Bayesian methods among nonclinical statisticians. Based on the survey results, a set of recommendations is provided to help guide the future advancement of Bayesian applications in nonclinical pharmaceutical statistics.
More Related Videos
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Biostatistics: Overview
Discrete variables are...
Analysis of Population Pharmacokinetic Data
Clinical Trials
There are four phases in a clinical trial. A phase one...
Statistical Methods for Analyzing Epidemiological Data
Bioequivalence Data: Statistical Interpretation

